CVSANYSEConsumer Defensive

Public company intelligence preview

COVISTA INC

10 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
10
5 filed in the last 30 days
Acquisition / disposition count
4/6
Buy / Sell
Unique insiders active in the last year
7
Current insider positions tracked
8
8 active, 0 exited

Insider compensation

Public aggregate: N/A average total compensation across covered insiders.

Governance movement

Public aggregate: 0 governance events in the last year.

Institutional ownership

Public aggregate: 0 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
6
Restricted-sale insiders, 1Y
5
Planned sale shares, 1Y
68.0K
Planned sale value, 1Y
$8.7M
Insiders covered
0
Comp records available
Personnel changes, 1Y
0
Board appointments, 1Y
0
Board departures, 1Y
0

Market context

Basic quote context for the preview.

Price
$122.94
Market cap
$4.3B
Volume
1,267
EPS
$1.20
Revenue
$487.0M
Employees
5.0K

Company note

Context before the data.

Company Overview

COVISTA INC (CVSA) operates in the Consumer Defensive sector and Education & Training Services industry, with business characteristics that align with a student-focused, regulation-sensitive education provider. Based on the filing summary, the company appears to be scaling through multiple education segments, with revenue growth across Chamberlain, Walden, and Medical and Veterinary programs. Its operations are driven by student enrollment trends, term timing, tuition collections, and regulatory eligibility for federal student aid. The business also appears to have meaningful exposure to policy changes affecting Title IV funding and program eligibility, which is especially important for investor monitoring.

Executive Compensation Practices

For a company like this, executive compensation is likely tied to a mix of revenue growth, enrollment performance, operating income, adjusted EPS, and cash flow generation, since those are the most visible business drivers in the latest results. The filing shows strong top-line growth, improved adjusted profitability, and significant share repurchases, so compensation metrics may favor both operational execution and capital allocation discipline. At the same time, segment-level volatility matters: Chamberlain’s adjusted operating income declined while Walden and Medical/Veterinary improved, suggesting that management incentives may also be linked to segment-specific enrollment and margin targets. In the Education & Training Services industry, pay packages often include annual bonuses, long-term equity awards, and performance conditions tied to regulatory compliance and student outcomes, not just financial performance.

Insider Trading Considerations

Insider trading patterns in this industry can be heavily influenced by enrollment cycles, academic term timing, regulatory developments, and reimbursement/aid policy changes, all of which can create meaningful information asymmetry. The company’s sensitivity to the newly enacted OBBBA, gainful employment rulemaking, and borrower-defense regulations means insiders may be especially cautious around trading windows because of potentially material nonpublic information. Strong cash generation, share repurchases, and segment-specific performance swings could also affect insider sentiment, with insiders potentially buying during periods when the market is overly focused on regulatory risk or short-term enrollment noise. For researchers and day traders, filings and trade timing should be watched closely around quarterly enrollment updates, regulatory announcements, and guidance changes, since those events may have outsized impact on both stock price and insider activity.

Unlock the full CVSA insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.